Laura Carrozzi
Overview
Explore the profile of Laura Carrozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chimera D, Maio S, Romei C, De Liperi A, Barbieri G, Tavanti L, et al.
Respir Med
. 2025 Jan;
237:107952.
PMID: 39826763
Background: The long-term evolution of COVID-19 in patients hospitalized during the pandemic's first wave remains largely unexplored. This study aimed to identify COVID-19 pulmonary phenotypes and their longitudinal patterns over...
2.
Casto E, Celi A, Madonna R, De Caterina R, Di Cianni F, Talarico R, et al.
RMD Open
. 2025 Jan;
10(4.
PMID: 39794272
No abstract available.
3.
Perrotta F, Lacedonia D, DAgnano V, Bianco A, Scioscia G, Tondo P, et al.
Front Oncol
. 2025 Jan;
14:1488157.
PMID: 39741973
Background: Interstitial lung diseases (ILDs) comprise a family of heterogeneous entities, primarily characterised by chronic scarring of the lung parenchyma. Among ILDs, idiopathic pulmonary fibrosis (IPF) is the most common...
4.
Carducci A, Arzilli G, Atomsa N, Lauretani G, Verani M, Pistelli F, et al.
PLoS One
. 2024 Sep;
19(9):e0309111.
PMID: 39348341
The epidemiological relevance of viral acute respiratory infections (ARIs) has been dramatically highlighted by COVID-19. However, other viruses cannot be neglected, such as influenza virus, respiratory syncytial virus, human adenovirus....
5.
Silvestri C, Stasi C, Profili F, Bartolacci S, Sessa E, Tacconi D, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200770
A few months after the COVID-19 pandemic onset, knowledge of SARS-CoV-2 infection and outcomes and treatments blew up. This paper aimed to evaluate the features of a Tuscany COVID-19 hospitalized...
6.
Mascalchi M, Puliti D, Cavigli E, Cortes-Ibanez F, Picozzi G, Carrozzi L, et al.
Eur J Radiol
. 2024 Aug;
179:111679.
PMID: 39163805
Purpose: To investigate the early radiological features and survival of Large Cell Carcinoma (LCC) cases diagnosed in low-dose computed tomography (LDCT) screening trials. Methods: Two radiologists jointly reviewed the radiological...
7.
Pistelli F, Meschi C, Carrozzi L
Lancet Reg Health Eur
. 2024 Jul;
42:100976.
PMID: 39050230
No abstract available.
8.
Bisanzi S, Puliti D, Picozzi G, Romei C, Pistelli F, Deliperi A, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927981
The role of total plasma cell-free DNA (cfDNA) in lung cancer (LC) screening with low-dose computed tomography (LDCT) is uncertain. We hypothesized that cfDNA could support differentiation between malignant and...
9.
Sbrana A, Cappelli S, Petrini I, Bernardini L, Massa V, Carrozzi L, et al.
Future Oncol
. 2024 May;
20(24):1745-1751.
PMID: 38709118
We retrospectively evaluated the effect of dabrafenib/trametinib combination in patients with BRAF-mutated non-small-cell lung cancer (NSCLC) treated in a single center from 2017 to 2022. The response and safety data...
10.
Visconti L, Celi A, Carrozzi L, Tinelli C, Crocetti L, Daviddi F, et al.
Vascul Pharmacol
. 2024 Apr;
155:107375.
PMID: 38663572
Anticoagulation is the first-line approach in the prevention and treatment of pulmonary embolism. In some instances, however, anticoagulation fails, or cannot be administered due to a high risk of bleeding....